DE68910275T2 - Arzneimittel und Methode zur Steigerung der mikrozirkulätorischen Durchfluss-Rate sowie des Volumens in den Kapillargefässen der Haut. - Google Patents
Arzneimittel und Methode zur Steigerung der mikrozirkulätorischen Durchfluss-Rate sowie des Volumens in den Kapillargefässen der Haut.Info
- Publication number
- DE68910275T2 DE68910275T2 DE89111110T DE68910275T DE68910275T2 DE 68910275 T2 DE68910275 T2 DE 68910275T2 DE 89111110 T DE89111110 T DE 89111110T DE 68910275 T DE68910275 T DE 68910275T DE 68910275 T2 DE68910275 T2 DE 68910275T2
- Authority
- DE
- Germany
- Prior art keywords
- capillaries
- skin
- volume
- increase
- flow rate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8822640A IT1231260B (it) | 1988-11-16 | 1988-11-16 | Farmaco e metodo per aumentare volume e velocita' del flusso microcircolatorio capillare a livello cutaneo |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68910275D1 DE68910275D1 (de) | 1993-12-02 |
DE68910275T2 true DE68910275T2 (de) | 1994-02-24 |
Family
ID=11198740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE89111110T Expired - Fee Related DE68910275T2 (de) | 1988-11-16 | 1989-06-19 | Arzneimittel und Methode zur Steigerung der mikrozirkulätorischen Durchfluss-Rate sowie des Volumens in den Kapillargefässen der Haut. |
Country Status (6)
Country | Link |
---|---|
US (1) | US5280020A (de) |
EP (1) | EP0369105B1 (de) |
AT (1) | ATE96323T1 (de) |
CA (1) | CA1333999C (de) |
DE (1) | DE68910275T2 (de) |
IT (1) | IT1231260B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4037658C2 (de) * | 1990-02-10 | 1993-11-04 | Nattermann A & Cie | Verwendung von derivaten des 2',4', 6'-trimethoxy-4-(1-pyrrolidinyl) butyrophenon |
IT1251840B (it) * | 1991-09-20 | 1995-05-26 | Schiena Ricerche | Uso di formulazioni liposomiali contenenti papaverina nel trattamento della impotenza maschile |
US6733776B1 (en) | 1992-04-02 | 2004-05-11 | Anticancer, Inc. | Method for promoting hair growth |
AU6554594A (en) * | 1993-04-02 | 1994-10-24 | Anticancer, Inc. | Method for delivering beneficial compositions to hair follicles |
US7556825B2 (en) | 1993-04-02 | 2009-07-07 | Anticancer, Inc. | Method for promoting hair growth |
IT1269634B (it) * | 1994-05-06 | 1997-04-08 | Indena Spa | Medicamento topico ad attivita' cicatrizzante |
US6844326B2 (en) | 1995-06-07 | 2005-01-18 | Anticancer, Inc. | Treatment of alopecia |
GB2331528B (en) * | 1997-11-20 | 2002-03-13 | Unilever Plc | Hair treatment composition |
EP2027087A2 (de) * | 2006-05-18 | 2009-02-25 | MannKind Corporation | Intrazelluläre kinase-inhibitoren |
US20100099640A1 (en) | 2007-05-04 | 2010-04-22 | Joannes Geuns | Tissue degeneration protection |
CN116406379A (zh) | 2020-10-22 | 2023-07-07 | 瑞泽恩制药公司 | 抗fgfr2抗体和其使用方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2092133B1 (de) * | 1970-05-06 | 1974-03-22 | Orsymonde | |
FR2134218A1 (en) * | 1971-04-27 | 1972-12-08 | Penciolelli Madeleine | Phloroglucinol aminoketones - vasodilators and antispasmodics |
US4742051A (en) * | 1977-06-30 | 1988-05-03 | University Of Tennessee Research Corporation | Antihypertensive compounds |
FR2539626B2 (fr) * | 1983-01-25 | 1985-06-21 | Lafon Labor | Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede |
DE3421468A1 (de) * | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
DE3682538D1 (de) * | 1985-05-15 | 1992-01-02 | Roshdy Ismail | Vitamin e-haltiges mittel zur verbesserung der eigenschaften des blutes. |
-
1988
- 1988-11-16 IT IT8822640A patent/IT1231260B/it active
-
1989
- 1989-06-19 EP EP89111110A patent/EP0369105B1/de not_active Expired - Lifetime
- 1989-06-19 DE DE89111110T patent/DE68910275T2/de not_active Expired - Fee Related
- 1989-06-19 AT AT89111110T patent/ATE96323T1/de not_active IP Right Cessation
- 1989-06-20 CA CA000603322A patent/CA1333999C/en not_active Expired - Fee Related
- 1989-06-21 US US07/369,145 patent/US5280020A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IT1231260B (it) | 1991-11-28 |
IT8822640A0 (it) | 1988-11-16 |
EP0369105B1 (de) | 1993-10-27 |
US5280020A (en) | 1994-01-18 |
CA1333999C (en) | 1995-01-17 |
ATE96323T1 (de) | 1993-11-15 |
EP0369105A1 (de) | 1990-05-23 |
DE68910275D1 (de) | 1993-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fabing et al. | Intravenous bufotenine injection in the human being | |
DE68910275T2 (de) | Arzneimittel und Methode zur Steigerung der mikrozirkulätorischen Durchfluss-Rate sowie des Volumens in den Kapillargefässen der Haut. | |
NO166448C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner. | |
ATE241365T1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
ES2171469T3 (es) | Composicion administrada por via nasal y preparacion que la contiene. | |
FR2713635B1 (fr) | Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. | |
FR2634376B1 (fr) | Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation | |
ATE165093T1 (de) | Aminoketonderivate | |
DE69327432D1 (de) | Heilmittel für wunden und hämorrhoiden | |
DE68911891D1 (de) | Verwendung von Acetyl-L-carnitin zur Behandlung von Katarakt, sowie pharmazeutische Zusammensetzungen für eine derartige Behandlung. | |
ATE206914T1 (de) | Verwendung von ursolsäure zur herstellung eines arzneimittels zur unterdrückung von metastasen | |
DE59206864D1 (de) | Arzneimittel enthaltend Protein C | |
ES2059588T3 (es) | Factor xiii para la prevencion de una hemorragia intraventricular. | |
ATE243527T1 (de) | Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen | |
EP0305277A3 (de) | Verwendung von 2-Amino-6-trifluormethoxybenzthiazol zur Herstellung eines Arzneimittels zur Behandlung von Schlafstörungen und Depressionen | |
DE69029040T2 (de) | Megakaryocytopoietischer faktor | |
DE69626401T2 (de) | Arzneimittel zur topischen anwendung | |
ATE139703T1 (de) | Aureobasidin enthaltendes arzneimittel | |
ATE130192T1 (de) | Verwendung von 15-deoxyspergualin als arzneimittel. | |
ATE223717T1 (de) | Topisch anzuwendendes abschäumendes arzneimittel zur behandlung von durch pityrosporum ovale verursachten hauterkrankungen | |
NO304518B1 (no) | Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem | |
ATE307587T1 (de) | Verwendung von thiaminen zur herstellung eines arzneimittels zur prophylaxe und zur therapie der diabetischen retinopathie und der diabetischen nephropathie | |
Cappon | Psychosomatic Aspects of Dermatology | |
Thijs | Age-related hypotensive effect of placebo and active treatment in patients older than 60 years | |
Goggans et al. | Chemical dependency and anxiety disorders. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |